Animal Hormone Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Global Animal Hormone Therapy Market is Segmented by Application (Growth Promotors, Performance Enhancers, and Other Applications), Animals (Companion Animals and Livestock), and Geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Animal Hormone Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Animal Hormone Therapy Market Size

Animal Hormone Therapy Market Summary
Study Period 2019 - 2030
Base Year For Estimation 2024
Forecast Data Period 2025 - 2030
Historical Data Period 2019 - 2023
CAGR 5.52 %
Fastest Growing Market Asia-Pacific
Largest Market North America

Major Players

Animal Hormone Therapy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Animal Hormone Therapy Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Animal Hormone Therapy Market Analysis

The Animal Hormone Therapy Market is expected to register a CAGR of 5.52% during the forecast period.

With the outbreak of COVID-19, the animal hormone therapy industry has faced both patterns. Initially, when the pandemic struck, with a rise in a sudden demand for meat, eggs, milk, and other animal food products, the industry faced a sudden spike in demand for growth promoters and performance enhancers. Since animal food processing is not such a process where human involvement and proximity are avoided with animals and humans, the units have to shut down amid the threat of spreading COVID-19. Thus, the market faced a demand reduction. However, the animal hormone used for therapeutic purposes for animals remained continuously in demand and supported the industry. Thus, COVID-19 is expected to show a considerable positive impact on the animal hormone therapy market.

The market growth is predominantly characterized by factors such as the growing burden of hormonal deficiency diseases in animals, rising demand for meat, and increasing animal husbandry. The growing burden of diseases in animals drives the market by focusing on hormones used in the treatment of hormonal deficiency diseases, neoplasia treatment, or replacement therapy. According to the BMC study journal published in November 2021, reproductive system tumors occupied the highest share (39.84%), followed by cutaneous tumors (28.05%), digestive tumors (18.70%), and ocular tumors (4.47%). Among the reproductive system tumors, breast tumors are the most common in female pet dogs, especially for Pekingese (11.43%). Similarly, according to the Pathogenesis of Endocrine Disease in Animals Article of April 2020, hyperthyroidism, Type I diabetes, primary hyperparathyroidism, and primary hyperadrenocorticism were the most common diseases in small animals that involved endocrine hypofunction. Animal hormones are used for fattening and production-boosting purposes in the animal food industry. 

In June 2021, the US Department of Agriculture reported a decline in beef production over a year but a strong demand for broilers, turkey, and pork. Moreover, the rate of animal husbandry is increasing all over the world, which largely concerns animal hormone use for the better health of animals. According to the Report of National Agricultural Statistics Services, United States, in April 2021, broiler production in the United States has been increasing over the last five decades. Thus, concerning the above facts, the animal hormone market is expected to witness significant growth over the forecast period owing to the increase in animal breeding and the rise in animal care.

Although animal hormone therapy has wide applications, the risks associated with the use of animal hormones and the stringent regulatory norms associated with their use may hamper the growth of the animal hormone therapy market.

Animal Hormone Therapy Industry Overview

The animal hormone therapy market is highly competitive, with several players across the world. In terms of market share, major players currently dominate the market. With the increasing burden of diseases and technological advancement in animal healthcare, many new players are expected to be part of the market over the forecast period. Some of the major players are Merck & Co. Inc., Boehringer Ingelheim, Elanco Inc., Virbac Group, and Vetoquinol SA.

Animal Hormone Therapy Market Leaders

  1. Boehringer Ingelheim

  2. Virbac Group

  3. Elanco Inc.

  4. Merck & Co. Inc.

  5. Soparfin SCA (Vetiquinol)

  6. *Disclaimer: Major Players sorted in no particular order
Animal Hormone Therapy Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Animal Hormone Therapy Market News

  • September 2022: Merck Animal Health, known as MSD Animal Health, announced it had signed a definitive agreement to acquire Vence.
  • March 2022: The Veterinary University Training and Research Center in Tripur District in Tamil Nadu launched a project for reducing the calving interval of Kangayam cows.
  • July 2021: ADM launched the customized antibiotic reduction program developed by Wisium Reduction. This program centralized Wisium's de-medication solutions across all species, offering a holistic approach.

Animal Hormone Therapy Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Burden of Hormonal Deficiency Diseases in Animals
    • 4.2.2 Rising Demand For Meat
    • 4.2.3 Increase in Animal Husbandry
  • 4.3 Market Restraints
    • 4.3.1 Side Effects Associated With Use of Animal Hormones
    • 4.3.2 Stringent Government Regulations Associated With Animal Hormones
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Application
    • 5.1.1 Growth Promotors
    • 5.1.2 Performance Enhancers
    • 5.1.3 Other Applications
  • 5.2 By Animals
    • 5.2.1 Companion Animals
    • 5.2.2 Livestock
  • 5.3 Geography
    • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
    • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia Pacific
    • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Merck & Co. Inc.
    • 6.1.2 Zoetis Inc.
    • 6.1.3 Elanco (Bayer Animal Health)
    • 6.1.4 Boehringer Ingelheim
    • 6.1.5 Bimeda Animal Health
    • 6.1.6 Soparfin SCA (Vetiquinol)
    • 6.1.7 Virbac Group
    • 6.1.8 CEVA Sante Animale
    • 6.1.9 HIPRA Animal Health
    • 6.1.10 Syntex SA
    • 6.1.11 Huvepharma
    • 6.1.12 Jurox Pty Ltd
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Animal Hormone Therapy Industry Segmentation

Hormones are the chemical messengers secreted in the bloodstream that coordinate with the nervous system and body organs of animals. Hormones are widely used in animals for therapeutic and physiological purposes, like for the treatment of hormonal deficiency diseases and to increase physiological activities that would enhance the production of food, milk, or growth. Animal hormones are also significantly used in hormone replacement therapy, neoplasia treatment, etc. 

The animal hormone therapy market is segmented by application (growth promotors, performance enhancers, and other applications), animals (companion animals and livestock), and geography (North America, Europe, Asia Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Application Growth Promotors
Performance Enhancers
Other Applications
By Animals Companion Animals
Livestock
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Animal Hormone Therapy Market Research FAQs

What is the current Animal Hormone Therapy Market size?

The Animal Hormone Therapy Market is projected to register a CAGR of 5.52% during the forecast period (2025-2030)

Who are the key players in Animal Hormone Therapy Market?

Boehringer Ingelheim, Virbac Group, Elanco Inc., Merck & Co. Inc. and Soparfin SCA (Vetiquinol) are the major companies operating in the Animal Hormone Therapy Market.

Which is the fastest growing region in Animal Hormone Therapy Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Animal Hormone Therapy Market?

In 2025, the North America accounts for the largest market share in Animal Hormone Therapy Market.

What years does this Animal Hormone Therapy Market cover?

The report covers the Animal Hormone Therapy Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Animal Hormone Therapy Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

UK Contraceptive Devices Industry Report

Statistics for the 2025 Animal Hormone Therapy market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Animal Hormone Therapy analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Animal Growth Promoters and Performance Enhancers Market Report Snapshots